Sean Tucker, Founder and Chief Scientific Officer, Vaxart is on a mission to expand the choices for a COVID-19 vaccine by producing an effective oral vaccine in tablet form which would allow for more efficient distribution and ease of administering particularly to needle-adverse people. Building on experience developing an oral tablet for an influenza vaccine, Vaxart has created a technology to trick the immune system in the intestine to recognize the protein as something that needed to mount immune response and then develop memory so that it works as a vaccine.